Psoriasis: Targets and Therapy

ISSN: 2230-326X

Archive: Volume 16, 2026

Original Research

Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study

Mrowietz U, Sommer R, Reguiai Z, Gerdes S, Daudén E, Weger W, Maul JT, Naldi L, Ghislain PD, Laws PM, De Jong EMGJ, Mburu S, Koscielny V, Massana E, Sapena V, Domenech A, Kasujee I, Augustin M

Psoriasis: Targets and Therapy 2026, 16:590189

Published Date: 12 May 2026

Original Research

Genetic Evidence Linking Immune Cell Subsets to Psoriatic Arthritis Susceptibility: A Mendelian Randomization Study

Wang H, Ma M, Wang C, Zhen Y, Li S

Psoriasis: Targets and Therapy 2026, 16:589733

Published Date: 16 April 2026

Original Research

Core Differentially Expressed Genes in Psoriasis Lesions: An Integrated Analysis of Four GEO Datasets

Ennouri M, Görmez Z, Bahloul E, Becha MK, Elleuch NB, Inal-Gültekin G

Psoriasis: Targets and Therapy 2026, 16:580680

Published Date: 3 April 2026

Review

Application of Trichoscopy and Novel Non-Invasive Imaging Techniques in the Diagnosis and Management of Patients with Scalp Psoriasis

Kuchnicka A, Fałkowska U, Konopelski P, Anderson A, Rakowska A, Kurzeja M, Olszewska M, Rudnicka L

Psoriasis: Targets and Therapy 2026, 16:549372

Published Date: 30 March 2026

Original Research

Indole-3-Lactic Acid Attenuates IMQ-Induced Psoriasiform Dermatitis in Mice via AhR-Dependent Suppression of IL-17A

Meng Z, Ren J, Lai Y, Lu S, Wu H, Jiang Y, Zhang Z, Tan G, Shi Z

Psoriasis: Targets and Therapy 2026, 16:585731

Published Date: 27 March 2026

Expert Opinion

The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis

Liang Y, Deng B, Ntawuyamara E, Bachelez H, Wang F, Zhang H, Zhang Z, Li Z, Dang L, Wang Y, Zou X, Wang L, Duan D, Chen H, Zheng W, Huang H, Zhang M, Cai Q, Chen Y, Zhang Y, Lu Z, Ren Y, Huang J

Psoriasis: Targets and Therapy 2026, 16:548700

Published Date: 16 February 2026

Original Research